Budget Pressures Are Hampering Science Efforts, FDA And NIH Heads Say
This article was originally published in The Pink Sheet Daily
Executive Summary
It will "certainly make it very hard to run an agency, when you don't know what your budget is, going forward," FDA Commissioner Margaret Hamburg says.
You may also be interested in...
FDA's Hamburg Says Japanese Crisis Shows Need To Fund Countermeasure Development
When Senators ask whether the U.S. is prepared for a nuclear disaster similar to one following the Japanese earthquake, FDA chief touts agency program that could help develop radiation treatments.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.